Xinghao Ai

1.1k total citations
36 papers, 520 citations indexed

About

Xinghao Ai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xinghao Ai has authored 36 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Xinghao Ai's work include Lung Cancer Treatments and Mutations (21 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Xinghao Ai is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Xinghao Ai collaborates with scholars based in China, United States and Singapore. Xinghao Ai's co-authors include Shun Lü, Shengping Shen, Xiaomin Niu, Yi Yang, Yi Zhao, Lan Shen, Haidong Wang, Zhen Ni Zhou, Rongrong Chen and Shun Lu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Xinghao Ai

33 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghao Ai China 14 245 190 189 123 49 36 520
Chunhua Ling China 17 422 1.7× 111 0.6× 112 0.6× 296 2.4× 27 0.6× 45 658
Feng‐Che Kuan Taiwan 12 146 0.6× 186 1.0× 167 0.9× 112 0.9× 24 0.5× 31 448
Dinghua Yang China 16 485 2.0× 398 2.1× 191 1.0× 387 3.1× 73 1.5× 41 1000
Ming Bai China 16 464 1.9× 242 1.3× 168 0.9× 291 2.4× 59 1.2× 57 839
Matthias Ludwig Germany 7 117 0.5× 102 0.5× 72 0.4× 43 0.3× 47 1.0× 10 347
SaeHeum Song United States 9 214 0.9× 132 0.7× 62 0.3× 84 0.7× 10 0.2× 18 501
Andrea Paccone Italy 10 166 0.7× 116 0.6× 107 0.6× 51 0.4× 31 0.6× 57 556

Countries citing papers authored by Xinghao Ai

Since Specialization
Citations

This map shows the geographic impact of Xinghao Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghao Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghao Ai more than expected).

Fields of papers citing papers by Xinghao Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghao Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghao Ai. The network helps show where Xinghao Ai may publish in the future.

Co-authorship network of co-authors of Xinghao Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghao Ai. A scholar is included among the top collaborators of Xinghao Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghao Ai. Xinghao Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yin, Liliang Xia, Hui Wang, et al.. (2025). Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survival. Cell Biology and Toxicology. 41(1). 106–106.
2.
Guan, Yanfang, et al.. (2024). SAFE-MIL: a statistically interpretable framework for screening potential targeted therapy patients based on risk estimation. Frontiers in Genetics. 15. 1381851–1381851. 1 indexed citations
3.
Chen, Mingyu, Xiaolin Xu, Xunxia Bao, et al.. (2023). Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing. Cell Death and Disease. 14(5). 330–330. 22 indexed citations
4.
Ai, Xinghao, et al.. (2022). Tagrisso incremental therapy in a case of meningeal metastasis of lung cancer with EGFR mutation: a case report. Translational Lung Cancer Research. 11(2). 323–330. 3 indexed citations
5.
Ai, Xinghao, Yongfeng Yu, Jun Zhao, et al.. (2022). Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting. Therapeutic Advances in Medical Oncology. 14. 4287524506–4287524506. 6 indexed citations
6.
7.
8.
Ai, Xinghao, Jiuwei Cui, Jiexia Zhang, et al.. (2020). Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641). Clinical Cancer Research. 27(3). 704–712. 31 indexed citations
9.
Ai, Xinghao, Rongrong Chen, Jiuwei Cui, et al.. (2020). Clonal dominance of EGFR and efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC.. Journal of Clinical Oncology. 38(15_suppl). e21501–e21501. 1 indexed citations
10.
Jin, Shidai, Chengzhi Zhou, Xue Hou, et al.. (2020). A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer. Translational Lung Cancer Research. 9(4). 1507–1515. 10 indexed citations
11.
12.
Ai, Xinghao, et al.. (2018). Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway. BMC Cancer. 18(1). 407–407. 26 indexed citations
13.
Niu, Xiaomin, et al.. (2017). P1.02-056 Tumor Heterogeneity in Lesion Specific Response Creates ROS1 Fusion Mediating Resistance to Gefitinib in EGFR 19 Deletion Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S521–S522. 1 indexed citations
14.
Ai, Xinghao, Jingwen Hou, Xiangyun Ye, et al.. (2016). Integrated discovery of FOXO1–DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer. Molecular BioSystems. 13(2). 330–337. 10 indexed citations
15.
Niu, Xiaomin, et al.. (2016). PS01.06: Tumor Heterogeneity in Lesion Specific Response Creates ROS1 Fusion Mediating Resistance to Gefitinib in EGFR 19 Deletion Lung Adenocarcinoma. Journal of Thoracic Oncology. 11(11). S273–S273. 2 indexed citations
16.
Ai, Xinghao, Shengping Shen, Lan Shen, & Shun Lü. (2015). An interaction map of small-molecule kinase inhibitors with anaplastic lymphoma kinase (ALK) mutants in ALK-positive non-small cell lung cancer. Biochimie. 112. 111–120. 21 indexed citations
17.
Yang, Yi, et al.. (2014). Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.. PubMed. 7(12). 8453–61. 57 indexed citations
18.
Zhou, Zhen Ni, Zhiwei Chen, Xiaohua Yang, et al.. (2012). Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 31(1). 34–34. 22 indexed citations
19.
Zhou, Zhen Ni, Xiaomin Niu, Ziming Li, et al.. (2012). Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients. Journal of Surgical Oncology. 106(6). 736–741. 50 indexed citations
20.
Li, Ziming, Yongfeng Yu, Jiade J. Lu, et al.. (2009). Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-small Cell Lung Cancer in China. Journal of Thoracic Oncology. 4(6). 702–709. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunhua Ling Breakdown of academic impact, for papers by Feng‐Che Kuan Breakdown of academic impact, for papers by Dinghua Yang Breakdown of academic impact, for papers by Ming Bai Breakdown of academic impact, for papers by Matthias Ludwig Breakdown of academic impact, for papers by SaeHeum Song Breakdown of academic impact, for papers by Andrea Paccone
Rankless by CCL
2026